Upgrade to SI Premium - Free Trial

Sarepta Therapeutics (SRPT) to Offer $350M in Common Stock

March 5, 2019 4:03 PM
Sarepta Therapeutics, Inc. (NASDAQ: SRPT), the leader in precision genetic medicine for rare diseases, today announced that it is offering ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Equity Offerings

Next Articles